Home Nucleus Pharmaceuticals U.S. Fibromyalgia Market to 2032

U.S. Fibromyalgia Market to 2032

Overview

The U.S. Fibromyalgia Market is expected to reach a 1,120.54 USD Million by 2032 and is projected to grow at a CAGR of 6.72% from 2025 to 2032.

Revenue, 2024 (USD Million)
746.97
Forecast, 2032 (USD Million)
1,120.54
CAGR, 2024 - 2032
6.72%
Report Coverage
U.S.

U.S. Fibromyalgia Market 2018-2032 USD Million

U.S. Fibromyalgia Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 746.97 USD Million
  • Projected Market Size (2032): 1,120.54 USD Million
  • CAGR (2025-2032): 6.72%

Key Findings of U.S. Fibromyalgia Market

  • The U.S. Fibromyalgia Market was valued at 746.97 USD Million in 2024.
  • The U.S. Fibromyalgia Market is likely to grow at a CAGR of 6.72% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 500.06 USD Million
  • The fastest growing segment Primary (Idiopathic) Fibromyalgia in Type Segment grew Fastest with a CAGR of 7.42% during the forecast period from 2024 to 2032.

U.S. Fibromyalgia Market Scope

U.S. Fibromyalgia Market Segmentation & Scope
End User
  • Hospital
  • Pain Clinics
  • Others
Distribution Channel
  • Direct Tender
  • Retail Sales
  • Others
Type
  • Brain & Hormonal Abnormalities (Secondary)
  • Primary (Idiopathic) Fibromyalgia

U.S. Fibromyalgia Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 746.97 USD Million
Market Value in 2032 1,120.54 USD Million
CAGR (2025-2032) 6.72%
Historic Data 2016-2023
Market Segments Covered End User,Distribution Channel,Type

Regional Insights:

  • Leading Market (2024-2032): U.S., leading in terms of revenue 746.97 USD Million in 2024
    • Key Country: U.S., leading in terms of revenue with value of 746.97 USD Million in 2024.

Segments and Scope

  • U.S. Fibromyalgia Market to 2032, By End User
    • Hospital is the largest segment in U.S. Fibromyalgia Market to 2032 with a revenue of 459.41 USD Million in the year 2024.
    • Hospital is the Fastest growing segment in U.S. Fibromyalgia Market to 2032 with a Growth rate of 7.04 % in forecast period 2025-2032.
  • U.S. Fibromyalgia Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in U.S. Fibromyalgia Market to 2032 with a revenue of 500.06 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in U.S. Fibromyalgia Market to 2032 with a Growth rate of 7.01 % in forecast period 2025-2032.
  • U.S. Fibromyalgia Market to 2032, By Type
    • Primary (Idiopathic) Fibromyalgia is the largest segment in U.S. Fibromyalgia Market to 2032 with a revenue of 400.23 USD Million in the year 2024.
    • Primary (Idiopathic) Fibromyalgia is the Fastest growing segment in U.S. Fibromyalgia Market to 2032 with a Growth rate of 7.42 % in forecast period 2025-2032.

U.S. Fibromyalgia Market Company Share Analysis

 
U.S. Fibromyalgia Market Company Share Analysis
U.S. Fibromyalgia Market Company Share Analysis

U.S. Fibromyalgia Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Fibromyalgia Market Geographical Sales Distribution, 2018-2032 USD Million

U.S. Fibromyalgia Market Company Profiling

U.S. Fibromyalgia Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The U.S. Fibromyalgia Market is segmented based on Segmentation End User,Distribution Channel,Type.
U.S. Fibromyalgia Market was valued at USD 746.97(Revenue in USD Million) in 2022.
U.S. Fibromyalgia Market is projected to grow at a CAGR of 6.72% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the U.S. Fibromyalgia Market, holding a largest market share of 500.06 USD Million in 2024

U.S. Fibromyalgia Market Scope

U.S. Fibromyalgia Market Segmentation & Scope
End User
  • Hospital
  • Pain Clinics
  • Others
Distribution Channel
  • Direct Tender
  • Retail Sales
  • Others
Type
  • Brain & Hormonal Abnormalities (Secondary)
  • Primary (Idiopathic) Fibromyalgia
Frequently Asked Questions
The U.S. Fibromyalgia Market is segmented based on Segmentation End User,Distribution Channel,Type.
U.S. Fibromyalgia Market was valued at USD 746.97(Revenue in USD Million) in 2022.
U.S. Fibromyalgia Market is projected to grow at a CAGR of 6.72% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Fibromyalgia Market for final year is USD 1,120.54 (USD Million).

U.S. Fibromyalgia Market Company Profiling

U.S. Fibromyalgia Market Company Profiling
Frequently Asked Questions
The U.S. Fibromyalgia Market is segmented based on Segmentation End User,Distribution Channel,Type.
U.S. Fibromyalgia Market was valued at USD 746.97(Revenue in USD Million) in 2022.
U.S. Fibromyalgia Market is projected to grow at a CAGR of 6.72% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Fibromyalgia Market for final year is USD 1,120.54 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES